Source: Kapitales ResearchHighlights

• 4DMedical advanced after a substantial shareholder disclosure from JPMorgan Chase & Co.
• Minerals 260 gained momentum amid continued investor interest in the exploration sector.
• Ora Banda Mining extended its rally as gold-related stocks remained in favour.

Australian shares delivered a mixed performance on 22 June 2026, but several stocks outperformed the broader market, attracting strong investor attention. Among the notable movers were 4DMedical Limited, Minerals 260 Limited and Ora Banda Mining Ltd, each recording gains of more than 5%.

4DMedical Climbs on Institutional Interest

4DMedical Limited (ASX: 4DX) rose 7.93% to AU$4.90, gaining AU$0.36 during the session. Investor sentiment appeared to benefit from a substantial shareholder notice lodged by JPMorgan Chase & Co. and its affiliates, which disclosed a 5.01% voting power in the company through interests in approximately 29.85 million ordinary securities. The filing signals growing institutional participation in the medical imaging technology company, which specialises in advanced respiratory imaging solutions.

Minerals 260 Extends Upward Momentum

Minerals 260 Limited (ASX: MI6) gained 6.18% to AU$0.987, rising AU$0.057. While no major price-sensitive announcement emerged during the session, the stock continued to attract investor interest as exploration companies remain closely watched for potential resource growth and project development opportunities. Strength across the resources sector also supported sentiment toward junior mining stocks.

Ora Banda Mining Benefits from Gold Sector Strength

Ora Banda Mining Ltd (ASX: OBM) added 5.35% to close at AU$1.28, up AU$0.064. The gold producer continued to benefit from positive sentiment across the precious metals sector, with investors maintaining interest in producers capable of delivering operational growth and production expansion. Gold-related equities have remained in focus as investors seek exposure to companies positioned to benefit from favourable commodity market conditions.

Market Focus Remains on Company-Specific Catalysts

The strong performances of 4DMedical, Minerals 260 and Ora Banda Mining highlight how company developments, institutional activity and sector-wide trends continue to drive stock-specific gains. Investors are likely to remain focused on future announcements, operational updates and broader market conditions as they assess the sustainability of recent share price momentum.Note- All data presented is based on information available at the time of writing.Disclaimer for Kapitales ResearchThe materials provided by Kapitales Research, including articles, news, data, reports, opinions, images, charts, and videos ("Content"), are intended for personal, non-commercial use only. The primary goal of this Content is to educate and inform readers. This Content is not meant to offer financial advice, nor does it include any recommendation or opinion that should be relied upon for making financial decisions. Certain Content on this platform may be sponsored or unsponsored, but it does not serve as a solicitation or endorsement to buy, sell, or hold any securities, nor does it encourage any specific investment activities. Kapitales Research is not authorized to provide investment advice, and we strongly advise users to seek guidance from a qualified financial professional, such as a financial advisor or stockbroker, before making any investment choices. Kapitales Research disclaims all liability for any direct, indirect, incidental, or consequential damages arising from the use of the Content, which is provided without any warranties. The opinions expressed by contributors or guests are their own and do not necessarily reflect the views of Kapitales Research. Media such as images or music used on this platform are either owned by Kapitales Research, sourced through paid subscriptions, or believed to be in the public domain. We have made reasonable efforts to credit sources where appropriate. Kapitales Research does not claim ownership of any third-party media unless explicitly stated otherwise. 

Customer Notice:

Nextgen Global Services Pty Ltd trading as Kapitales Research (ABN 89 652 632 561) is a Corporate Authorised Representative (CAR No. 1293674) of Enva Australia Pty Ltd (AFSL 424494). The information contained in this website is general information only. Any advice is general advice only. No consideration has been given or will be given to the individual investment objectives, financial situation or needs of any particular person. The decision to invest or trade and the method selected is a personal decision and involves an inherent level of risk, and you must undertake your own investigations and obtain your own advice regarding the suitability of this product for your circumstances. Please be aware that all trading activity is subject to both profit & loss and may not be suitable for you. The past performance of this product is not and should not be taken as an indication of future performance.

Kapitales Research, Level 13, Suite 1A, 465 Victoria Ave, Chatswood, NSW 2067, Australia | 1800 005 780 | info@kapitales.com.au